Weiwei Li; Yong Sun; Tai Ma; Wanhang Lu; Nan Sa; Lei Gong; Xinxin Wang; Jiaming Tian; Yongkang Xiao; Liangliang Jiang; Xiangying Wang; Ge Bu; Guozhou Liu; Xiaoxue Yang; Zhuhui Zhang; Wenchang Li; Jinbao Huang; Zhiguo Cao; Weiwei Li; Yong Sun; Tai Ma; Wanhang Lu; Nan Sa; Lei Gong; Xinxin Wang; Jiaming Tian; Yongkang Xiao; Liangliang Jiang; Xiangying Wang; Ge Bu; Guozhou Liu; Xiaoxue Yang; Zhuhui Zhang; Wenchang Li; Jinbao Huang; Zhiguo Cao

doi:10.46234/ccdcw2025.179

[1]

Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine 2020;38 Suppl 1:A31-40. http://dx.doi.org/10.1016/j.vaccine.2019.07.078.

[2]

Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993;341(8846):703 − 4. https://doi.org/10.1016/0140-6736(93)90480-5.

[3]

Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh, Albert MJ, Ansaruzzaman M, Bardhan PK, Faruque ASG, Faruque SM. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 1993;342(8868):387 − 90. https://doi.org/10.1016/0140-6736(93)92811-7.

[4]

Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet 2017;390(10101):1539 − 49. https://doi.org/10.1016/s0140-6736(17)30559-7.

[5]

Yu L, Zhou YY, Wang RB, Lou J, Zhang LJ, Li J, et al. Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009. PLoS One 2012;7(6):e38633. https://doi.org/10.1371/journal.pone.0038633.

[6]

Zhang P, Zhou HJ, Diao BW, Li FJ, Du PC, Li J, et al. A molecular surveillance reveals the prevalence of Vibrio cholerae O139 isolates in China from 1993 to 2012. J Clin Microbiol 2014;52(4):1146 − 52. https://doi.org/10.1128/jcm.03354-13.

[7]

Tao T, Meng XC, Lu MJ, Lin H, Fu GL, Han X. Identification of the first case of Vibrio cholerae O₁₃₉ and its toxin, Anhui Province. J Hyg Res 1998;27(S1):18. https://doi.org/10.19813/j.cnki.weishengyanjiu.1998.s1.007.

[8]

Dorman MJ, Domman D, Uddin MI, Sharmin S, Afrad MH, Begum YA, et al. High quality reference genomes for toxigenic and non-toxigenic Vibrio cholerae serogroup O139. Sci Rep 2019;9(1):5865. https://doi.org/10.1038/s41598-019-41883-x.

[9]

Wang JZ, Yan MY, Gao H, Lu X, Kan B. Vibrio cholerae colonization of soft-shelled turtles. Appl Environ Microbiol 2017;83(14):e00713 − 17. https://doi.org/10.1128/aem.00713-17.

[10]

Ramamurthy T, Pragasam AK, Taylor-Brown A, Will RC, Vasudevan K, Das B, et al. Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic. Nat Commun, 2022;13(1):3864. https://doi.org/10.1038/s41467-022-31391-4.

[11]

Luo Y, Ye JL, Payne M, Hu DL, Jiang JM, Lan RT. Genomic epidemiology of Vibrio cholerae O139, Zhejiang Province, China, 1994-2018. Emerg Infect Dis 2022;28(11):2253 − 60. https://doi.org/10.3201/eid2811.212066.

[12]

Liang XY, Pei TT, Li H, Zheng HY, Luo H, Cui Y, et al. VgrG-dependent effectors and chaperones modulate the assembly of the type VI secretion system. PLoS Pathog 2021;17(12):e1010116. https://doi.org/10.1371/journal.ppat.1010116.

[13]

Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. Antibiotic resistance in Vibrio cholerae: understanding the ecology of resistance genes and mechanisms. Vaccine 2020;38 Suppl 1:A83-92. http://dx.doi.org/10.1016/j.vaccine.2019.06.031.